
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
Shuba Krishnan, Hampus Nordqvist, Anoop T. Ambikan, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100159-100159
Open Access | Times Cited: 97
Shuba Krishnan, Hampus Nordqvist, Anoop T. Ambikan, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100159-100159
Open Access | Times Cited: 97
Showing 1-25 of 97 citing articles:
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts
Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 708
Closed Access | Times Cited: 100
Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 708
Closed Access | Times Cited: 100
Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms
Rafał Butowt, Katarzyna Bilińska, Christopher S. von Bartheld
Trends in Neurosciences (2022) Vol. 46, Iss. 1, pp. 75-90
Open Access | Times Cited: 84
Rafał Butowt, Katarzyna Bilińska, Christopher S. von Bartheld
Trends in Neurosciences (2022) Vol. 46, Iss. 1, pp. 75-90
Open Access | Times Cited: 84
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
G. S. Gupta
Inflammation (2022) Vol. 45, Iss. 6, pp. 2091-2123
Open Access | Times Cited: 76
G. S. Gupta
Inflammation (2022) Vol. 45, Iss. 6, pp. 2091-2123
Open Access | Times Cited: 76
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 67
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 67
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
Elisa Saccon, Xi Chen, Flora Mikaeloff, et al.
iScience (2021) Vol. 24, Iss. 5, pp. 102420-102420
Open Access | Times Cited: 64
Elisa Saccon, Xi Chen, Flora Mikaeloff, et al.
iScience (2021) Vol. 24, Iss. 5, pp. 102420-102420
Open Access | Times Cited: 64
An investigation on the molecular structure, interaction with metal clusters, anti-Covid-19 ability of 2-deoxy-D-glucose: DFT calculations, MD and docking simulations
G. Venkatesh, Yudibeth Sixto‐López, P. Vennila, et al.
Journal of Molecular Structure (2022) Vol. 1258, pp. 132678-132678
Closed Access | Times Cited: 57
G. Venkatesh, Yudibeth Sixto‐López, P. Vennila, et al.
Journal of Molecular Structure (2022) Vol. 1258, pp. 132678-132678
Closed Access | Times Cited: 57
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2
Werner C. Albrich, Tarini Shankar Ghosh, Sinead Ahearn‐Ford, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Werner C. Albrich, Tarini Shankar Ghosh, Sinead Ahearn‐Ford, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 53
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 53
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients
Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100779-100779
Open Access | Times Cited: 52
Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100779-100779
Open Access | Times Cited: 52
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
Chandan Bhowal, Sayak Ghosh, Debapriya Ghatak, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 6, pp. 1325-1343
Open Access | Times Cited: 44
Chandan Bhowal, Sayak Ghosh, Debapriya Ghatak, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 6, pp. 1325-1343
Open Access | Times Cited: 44
Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients
Veronica Ghini, Gaia Meoni, Lorenzo Pelagatti, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 4, pp. e1010443-e1010443
Open Access | Times Cited: 42
Veronica Ghini, Gaia Meoni, Lorenzo Pelagatti, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 4, pp. e1010443-e1010443
Open Access | Times Cited: 42
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models
Yisheng Jiang, Yong‐Qiang Deng, Huanhuan Pang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37
Yisheng Jiang, Yong‐Qiang Deng, Huanhuan Pang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37
Metabolomics meets systems immunology
Jianbo Fu, Feng Zhu, Cheng‐Jian Xu, et al.
EMBO Reports (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 25
Jianbo Fu, Feng Zhu, Cheng‐Jian Xu, et al.
EMBO Reports (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 25
Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients
Georgy Berezhnoy, Rosi Bissinger, Anna Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Georgy Berezhnoy, Rosi Bissinger, Anna Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Infection with SARS-CoV-2 can cause pancreatic impairment
Wei Deng, Linlin Bao, Zhiqi Song, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Wei Deng, Linlin Bao, Zhiqi Song, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19
Joseph W. Guarnieri, Jeffrey Haltom, Yentli E. Soto Albrecht, et al.
Pharmacological Research (2024) Vol. 204, pp. 107170-107170
Open Access | Times Cited: 8
Joseph W. Guarnieri, Jeffrey Haltom, Yentli E. Soto Albrecht, et al.
Pharmacological Research (2024) Vol. 204, pp. 107170-107170
Open Access | Times Cited: 8
Targeted Down Regulation Of Core Mitochondrial Genes During SARS-CoV-2 Infection
Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 36
Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 36
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
Anoop T. Ambikan, Hong Yang, Shuba Krishnan, et al.
Cell Systems (2022) Vol. 13, Iss. 8, pp. 665-681.e4
Open Access | Times Cited: 30
Anoop T. Ambikan, Hong Yang, Shuba Krishnan, et al.
Cell Systems (2022) Vol. 13, Iss. 8, pp. 665-681.e4
Open Access | Times Cited: 30
Direct and indirect impact of SARS-CoV-2 on the brain
Jean Pierre Schatzmann Peron
Human Genetics (2023) Vol. 142, Iss. 8, pp. 1317-1326
Open Access | Times Cited: 17
Jean Pierre Schatzmann Peron
Human Genetics (2023) Vol. 142, Iss. 8, pp. 1317-1326
Open Access | Times Cited: 17
Metabolomics and lipidomics strategies in modern drug discovery and development
Giuseppe Astarita, Rachel S. Kelly, Jessica Lasky‐Su
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103751-103751
Open Access | Times Cited: 17
Giuseppe Astarita, Rachel S. Kelly, Jessica Lasky‐Su
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103751-103751
Open Access | Times Cited: 17
Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence
Stella Dimitsaki, George Gavriilidis, Vlasios K. Dimitriadis, et al.
Artificial Intelligence in Medicine (2023) Vol. 137, pp. 102490-102490
Open Access | Times Cited: 15
Stella Dimitsaki, George Gavriilidis, Vlasios K. Dimitriadis, et al.
Artificial Intelligence in Medicine (2023) Vol. 137, pp. 102490-102490
Open Access | Times Cited: 15
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Host Plasma Microenvironment in Immunometabolically Impaired HIV Infection Leads to Dysregulated Monocyte Function and Synaptic Transmission Ex Vivo
Flora Mikaeloff, Marco Gelpi, Alejandra Escós, et al.
Advanced Science (2025)
Open Access
Flora Mikaeloff, Marco Gelpi, Alejandra Escós, et al.
Advanced Science (2025)
Open Access
Metabolomic characteristics and related pathways in patients with different severity of COVID-19: a systematic review and meta-analysis
Chenghao Bi, Junjie He, Yu Yuan, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Chenghao Bi, Junjie He, Yu Yuan, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Adult Long Coronavirus Disease 2019
Ivette F. Emery, Clifford J. Rosen
Infectious Disease Clinics of North America (2025)
Closed Access
Ivette F. Emery, Clifford J. Rosen
Infectious Disease Clinics of North America (2025)
Closed Access